8 April 2023
RNZ's Kim Hill speaks to a participant in our CAR T-cell clinical trial, poet Michele Leggott.
Michele Leggott's latest book of poetry, Face to the Sky, explores her encounter with 19th-century New Zealand botanical artist Emily Cumming Harris.
But there's more to this story - Michele was battling non-Hodgkin's lymphoma while working on the book.
In early 2020, Michele received her diagnosis, just as the Covid-19 lockdowns began. Chemotherapy, radiotherapy, and a stem cell transplant in 2021 failed to cure her cancer. Finally, in early 2022, Michele was able to participate in a CAR T-cell therapy trial at the Malaghan Institute in Wellington.
"This is the future ... The Malaghan trial, the goal of that is to get publicly funded CAR T in this country so that you don't have to be on a trial to get it. If that can happen, it'll bring down hospital costs, you'll save lives."
In Focus: Mastering the technology behind automated CAR T-cell manufacture
14 September 2023
RNZ: New Zealand developed cancer treatment one step closer to market
17 May 2023
Malaghan PhD student receives Māori Cancer Researcher Award
28 April 2023
In Focus: From the lab to the clinic in New Zealand’s first CAR T-cell therapy clinical trial
8 March 2023
Professor Mike Berridge: A journey through the frontiers of the biological sciences
28 November 2022
In focus: A new chapter in mRNA vaccine technology
11 October 2022